Tuesday, April 10, 2012

Marshall Gordon's Biotech Picks

Marshall Gordon is a health care analyst at Clear Bridge Advisors, a New York based asset manager with an AUM of $55B.

"I think we are beginning to see signs of life amongst biotechs, with new products coming to market that are gaining traction. Innovation is a great way to get paid, in any market environment or regulatory environment."

No comments:

Post a Comment